Welcome to our dedicated page for Regis SEC filings (Ticker: RGS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Regis Corporation (NasdaqGM: RGS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, along with AI-assisted summaries to help interpret key points. As a Minnesota-incorporated public company in the haircare industry, Regis files annual reports on Form 10-K, quarterly updates on Form 10-Q, and current reports on Form 8-K that describe material events and financial results.
Through its Form 10-K and Form 10-Q filings, Regis reports consolidated revenue, system-wide revenue, operating income, net income, adjusted EBITDA, and system-wide same-store sales, as well as segment information for franchise and company-owned salons. These reports also include discussions of risk factors, liquidity, financing arrangements, tax matters, and non-GAAP reconciliations that the company uses to supplement its financial presentation.
Form 8-K filings for Regis document earnings announcements, leadership changes, and shareholder meeting outcomes. Examples include 8-Ks furnished in connection with quarterly and annual financial results, and an 8-K describing the transition from one Chief Executive Officer to an interim CEO. Another 8-K details voting results from the annual meeting, covering director elections, advisory say-on-pay approval, ratification of the independent registered public accounting firm, approval of an amended stock purchase plan, and advisory ratification of a Tax Benefits Preservation Plan.
The company’s definitive proxy statement on Schedule 14A provides further detail on Board composition, executive compensation, governance policies, and shareholder proposals, as well as information about a previously effected reverse stock split. On Stock Titan, AI-generated highlights can help you quickly understand these lengthy documents by extracting key themes, governance decisions, and compensation structures, while links to the full text allow for deeper review.
In addition, this page can surface insider-related filings such as Forms 3, 4, and 5 when available, enabling users to track changes in beneficial ownership by Regis directors and officers. Real-time updates from EDGAR combined with AI explanations make it easier to follow how SEC disclosures reflect Regis Corporation’s financial condition, strategic actions, and corporate governance over time.
Regis Corporation (RGS)2,727 shares of common stock on November 14, 2025 at a price of $0 per share. Following this grant, the director beneficially owns 8,068 shares of Regis common stock in total. The award vests on the earlier of November 14, 2026 or the company’s next annual meeting of shareholders after November 14, 2025, contingent on the director’s continued service and the terms of the grant agreements.
Regis Corporation (RGS)2,727 shares of common stock at a price of $0, increasing their holdings to 5,927 shares held directly. The award is scheduled to vest on the earlier of November 14, 2026 or the company’s next annual meeting of shareholders after November 14, 2025, provided the director continues to serve the company and meets the other terms of the grant agreement.
Regis Corporation (RGS) reported an equity grant to one of its directors. On November 14, 2025, the director acquired 2,727 shares of common stock at a price of $0, increasing the director’s beneficial ownership to 8,114 shares, held directly. This was reported on a Form 4 filed for a single reporting person.
The shares were granted as an equity award that vests on the earlier of November 14, 2026 or the company’s next annual meeting of shareholders after November 14, 2025, provided the director continues to serve on the board and meets the other terms of the grant agreements. This reflects routine director compensation in stock rather than a market purchase.
Regis Corporation (RGS) reported that one of its directors received an award of 2,727 shares of common stock on November 14, 2025. The award was granted at a stated price of $0, indicating a stock grant rather than an open-market purchase.
After this grant, the director beneficially owns 13,567 shares in total. The shares vest on the earlier of November 14, 2026 or the company’s next annual meeting of shareholders after November 14, 2025, provided the director continues to serve the company and meets the other terms and conditions of the grant agreement.
Regis Corporation reported a return to profitability for the quarter ended September 30, 2025. Total revenue was $58.96 million, up from $46.06 million a year ago, driven by the December 2024 Alline acquisition which lifted company-owned salon revenue to $20.21 million (from $0.79 million). Operating income rose to $5.92 million as lower general and administrative costs offset higher rent and company-owned expenses.
After $5.27 million of interest expense and a $1.00 million gain from reducing the Alline earn-out liability, net income was $1.36 million, or $0.49 diluted EPS, compared with a loss last year. Cash from operations was $2.28 million. Cash and cash equivalents were $16.56 million; total available liquidity, net of the minimum liquidity covenant, was $25.5 million, with $19.0 million available under the revolver.
Franchise trends were softer: royalties fell to $14.04 million and franchise rent lines declined with fewer franchise salons, while system-wide same-store sales improved to 0.9%. Debt included a term loan of $117.04 million plus $6.78 million of paid-in-kind interest, maturing in 2029. Shares outstanding were 2,480,493 as of November 5, 2025.
Regis Corporation furnished an 8-K announcing financial results for its fiscal quarter ended September 30, 2025. The company noted that the information provided under Item 2.02 is furnished and not deemed filed, and it is not incorporated by reference into other filings.
Detailed figures and commentary are contained in the attached Exhibit 99.1 press release dated November 12, 2025.
Regis Corporation reported the results of its Annual Meeting held on October 28, 2025. Shareholders elected five directors and approved the advisory say‑on‑pay vote.
They ratified Grant Thornton LLP as independent auditor. The Amended and Restated 1991 Contributory Stock Purchase Plan was approved, and shareholders gave advisory ratification to extend the Tax Benefits Preservation Plan.
Key vote totals included: say‑on‑pay For 629,139; auditor ratification For 1,661,370; stock purchase plan For 609,366; tax benefits preservation plan extension For 702,830.
Form 144 for RGS (Regis Corp) notifies the market of a proposed sale of 437 common shares through Fidelity Brokerage Services (900 Salem St, Smithfield, RI) with an approximate sale date of 09/26/2025. The filing reports the shares were acquired under an option granted 05/05/2022 and payment is indicated as cash. The issuer's total shares outstanding are listed as 2,435,981, giving the proposed block an aggregate market value of $12,454.50. The filer also reported recent sales by the same person: 9/18/2025 — 9,626 shares for $278,342.53 and 9/19/2025 — 937 shares for $26,719.49. The signer attests there is no undisclosed material adverse information.
Form 144 notice for Regis Corp (RGS) shows a proposed sale of 937 common shares through Fidelity Brokerage Services with an aggregate market value of $26,719.50, to be sold approximately on 09/19/2025 on NASDAQ. The filing lists 2,435,981 shares outstanding for the class and indicates the securities were acquired under options granted on 05/05/2022 with payment in cash.
The filing also discloses that the same person previously sold 9,626 common shares on 09/18/2025 for gross proceeds of $278,342.53. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information about the issuer.
Form 144 filed for Regis Corporation (RGS) reports a proposed sale of 9,626 shares of Common stock through Fidelity Brokerage Services with an aggregate market value of $278,342.33. The filing lists approximately 2,435,981 shares outstanding and an approximate sale date of 09/18/2025. The securities are shown as acquired in connection with an option (grant date 05/05/2022) and the indicated acquisition date is 09/18/2025; the consideration on sale is listed as cash. The filer states there were no securities sold by the person in the past three months and signs the required attestation that they are not aware of any undisclosed material adverse information about the issuer.
FAQ
What is the current stock price of Regis (RGS)?
What is the market cap of Regis (RGS)?
